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Introduction 
Tuberous sclerosis is an autosomal dominant genetic 
disease that causes benign lesions in various organs 
such as the kidneys, heart, liver, eyes, lungs, and skin.1 
The pathogenesis of this disease involves mutation of 
either gene TSC1 or gene TSC2, that code protein 
hamartin and tuberin respectively. These genes play 
an important role in suppression of tumor growth.2 
Patients with tuberous sclerosis present with variety of 
symptoms that include seizures, intellectual disability, 
developmental delay, behavioral disorders, skin, lung 
and kidney lesions; it accounts to be the most common 
genetic cause of epilepsy.3 
The diagnosis of tuberous sclerosis is made on the 
presence of major and minor criteria (detailed in table 
I) which are then analyzed to produce a definite or 
possible diagnosis.  
1) Definite diagnosis: Two major features or one major 
feature with ≥2 minor features.  
2) Possible  diagnosis: Either one major feature or ≥2 
minor features.4 
Here we present a case of tuberous sclerosis who 
presented with fits. 
 
Case Report 
A 40 years old female, resident of Azad Kashmir, 
married for 14 years, having no children presented to 
our Emergency Department with history of multiple 
episodes of generalized tonic clonic fitfor last 3 days, 
each lasting for few seconds to few minutes. Fits were 
associated with frothing from mouth, tongue bite and 
urinary incontinence. No fecal incontinence or up 
rolling of eyes were noted. These fits were followed by 
postictal state that lasted for few minutes. There was 
also associated history of fever for 2 days which was 
high grade, intermittent, undocumented with no 
evening rise or history of chills or rigors. Patient also 
had complaint of generalized abdominal pain which 
was gradual in onset, mild in intensity, non-radiating 
but was associated with constipation. There was no 
history of sore throat, cough, sputum, loose motion or 
vomiting. 
Patient was a diagnosed case of epilepsy for past 12 
years with good compliance but poor control. She was 
also a known hypertensive for 15 years taking 
Valsartan/Amlodipine/Hydrochlorthiazide 
combination (160/10/25 mg) with poor compliance 
and control. There was history of miscarriage as well. 
Right nephrectomy was performed 6 months, record in 
this regard was not available. Patient belonged to poor 
socioeconomic background. 
On general physical examination, patient was a 
middle-aged lady of average built and height, lying 
comfortably in bed, was oriented in time, place and 
person. Her vitals showed blood pressure 110/ 60 
mmHg, pulse 80/min, respiratory rate 22/min and 
temperature 98.60F. Patient had multiple 
angiofibromas on the face more prominent on the 
cheeks and nasolabial folds. An irregularly shaped, 
irregularly thickened slightly elevated skin colored 
patch (Shagreen patch), was appreciated on the lower 
back. 5 -6 hypomelanotic macules were also noted on 
the lower limbs. Abdominal examination was 
unremarkable apart from a scar on right side. No 
abnormality was picked on rest of systemic 
examination. 
During her stay in the hospital she in addition to 
routine hematological and biochemical testing, ECG, 
ultrasound abdomen, CT scan of Brain and MRI brain. 
Her blood complete picture, LFTS, Serum electrolytes 
were normal. Serum creatinine was 1.8 mg/dl and 
urea 71 mg/dl. GFR was 35ml/min/1.73m2 . Urine RE 
showed blood ++ with few RBCS and pus cells. On 
ultrasound abdomen right kidney was not visualized 
but left kidney showed multiple angiomyolipoma. CT 
brain showed multiple calcified sub ependymal 
nodules with multiple calcified nodules in right frontal 
lobe and left posterior parietal lobe representing 
cortical tubers. MRI Brain findings were suggestive of 
cortical, subcortical and sub ependymal tubers in 
bilateral cerebral hemisphere 
On the basis of clinical signs and investigations, 
patient was diagnosed as a case of tuberous sclerosis. 
She was given intravenous antiepileptics to prevent 
further episodes of fits. She had no further episodes of 
fits during her stay in the hospital. Nephrologist 
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consultation was done for her deranged RFTs and 
their advice was followed.  Blood pressure was 
adequately managed. Patient was discharged on oral 
antiepileptic and oral antihypertensive with advice to 
take medications with good compliance and follow up 
in Out Patient Department (OPD). Patient was also 
advised follow up in Eye, Dental and Dermatological 
department for further management in multi-
disciplinary way. 
 
Major Criteria Minor Criteria 
1.Hypomelanotic macules (≥3, at least 5-mm 
diameter) 
2.Angiofibromas (≥3) or fibrous cephalic plaque 
3.Ungual fibromas (≥2) 
4.Shagreen patch 
5.Multiple retinal hamartomas 
6.Cortical dysplasias∗ 
7.Subependymal nodules 
8.Subependymal giant cell astrocytoma 
9.Cardiac rhabdomyoma 
10.Lymphangioleiomyomatosis (LAM)† 
11.Angiomyolipomas (≥2)† 
∗ Includes tubers and cerebral white matter radial migration lines. 
† A combination of the two major clinical features (LAM and 
angiomyolipomas) without other features does not meet criteria for 
a definite diagnosis 
 
 
1.Dental enamel pits: (≥3) 
2.Intraoral fibromas (≥2) 
3.Non-renal hamartomas 
4.Retinal achromic patch 
5.'Confetti' skin lesions 
6.Multiple renal cysts 
 
 
Table 1: Major and minor criteria of Tuberous sclerosis. 
 
Discussion 
Tuberous sclerosis can present in a diverse pattern by 
involving multiple organ of human body. Some of 
these manifestations can be critical and may require 
immediate management.4 Our patient presented in 
emergency department with complaint of seizures. 
Cortical tubers which are a form of focal cortical 
dysplasias are present in about 90% of patients with 
tuberous sclerosis and are the cause of epilepsy in 
these patients.4 Recommended first line therapy in 
these patients is Vigabatrin followed by surgery in 
refractory cases. Our patient responded to 
antiepileptics. 
Significant morbidity and mortality is caused by renal 
lesions in tuberous sclerosis patients and account for 
the second leading cause of premature death.4 Our 
patient had multiple renal angiomyolipomas. In 
symptomatic cases, embolization of angiomyolipoma 
in these patients is recommended followed by course 
of corticosteroids and in asymptomatic cases mTOR 
inhibitor is the first line therapy.4Although 
nephrectomy should be avoided but our patient had 
undergone nephrectomy in the past.  
Our patient had 6-7 hypomelanotic macules which are 
one of the major criteria for the diagnosis of tuberous 
sclerosis and are present in about 90% of the patients.5 
(Figure 1) 50% of patients with tuberous sclerosis have 
Shagreen patches that are highly specific for tuberous 
sclerosis.5 (Figure 2) This is among the major criteria of 
tuberous sclerosis. Angiofibromas are present on the 
face in about 75% of the patients as were in our 
patient.5 (Figure 3 and 4).  
CT scan revealed the presence of subependymal 
nodules, which are benign growths that develop along 
the wall of the ependymal lining of the ventricles in 
80% of tuberous sclerosis patients.6  30-40 % of female 
patients have cystic pulmonary changes consistent 
with lymphangioleiomyomatosis but only 10-20% of 
male patients have them.7 These individuals should 
have annual pulmonary function testing and mTOR 
inhibitors may be used in symptomatic patients. 4 
Certain manifestations, like seizures, continue to 
manifest throughout the life of these patients. 
Therefore they require good surveillance for better 
management of their disease manifestations. 
Management of tuberous sclerosis can be done a lot 
better by opting a multidisciplinary approach. 
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